openPR Logo
Press release

Market Segmentation, Major Trends, and Competitive Analysis of the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (RhGCSF) Market

02-25-2026 11:52 AM CET | Health & Medicine

Press release from: The Business Research Company

Recombinant Human Granulocyte Colonystimulating Factor Injection Rhgcsf Market

Recombinant Human Granulocyte Colonystimulating Factor Injection Rhgcsf Market

The recombinant human granulocyte colony-stimulating factor injection (rhG-CSF) market is on track for substantial growth as medical needs and pharmaceutical innovations continue to evolve. This market is shaped by increasing healthcare demands, advancements in drug formulations, and strategic moves by key industry players, all pointing towards a promising future for rhG-CSF therapies.

Projected Market Growth and Size of the Recombinant Human Granulocyte Colony-Stimulating Factor Injection rhG-CSF Market
The rhG-CSF market is anticipated to expand significantly over the coming years, reaching a market size of $5.86 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 8.6%. The upward trend is mainly driven by a rise in cancer cases worldwide, growing preference for long-acting injectable treatments, wider acceptance of biosimilar drugs, improved access to specialty biologics, and the strengthening of hospital supportive care protocols. Key trends expected to influence this market include the increasing adoption of biosimilar G-CSF injections, the introduction of prefilled syringe delivery formats, expanded use in chemotherapy supportive care, demand for long-acting pegylated formulations, and the growing incorporation of combination supportive therapies.

Download a free sample of the recombinant human granulocyte colonystimulating factor injection rhgcsf market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33285&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR

Prominent Companies Leading the Recombinant Human Granulocyte Colony-Stimulating Factor Injection rhG-CSF Market
Several major pharmaceutical companies currently dominate this market, including Pfizer Inc., Novartis AG, Amgen Inc., Intas Pharmaceuticals Ltd., Kyowa Kirin Co. Ltd., Dr. Reddy's Laboratories Ltd., Cadila Pharmaceuticals Ltd., Biocon Limited, North China Pharmaceutical Group Corporation, Shijiazhuang Pharmaceutical Group Co. Ltd., Emcure Pharmaceuticals Ltd., Harbin Pharmaceutical Group Co. Ltd., Reliance Life Sciences Pvt. Ltd., Jiuyuan Gene Engineering Co. Ltd., Qilu Pharmaceutical Co. Ltd., Amoytop Biotech Co. Ltd., Kexing Biopharm Co. Ltd., Sunway Biotech Co. Ltd., Apotex Inc., and Wuzhong Pharmaceutical Group Co. Ltd.

Strategic Acquisition to Strengthen Market Reach and Portfolio
In April 2023, Assertio Holdings Inc., a specialty pharmaceutical company based in the United States, acquired Spectrum Pharmaceuticals Inc. for an undisclosed sum. This acquisition aims to enhance Assertio's commercial capabilities and broaden its therapeutic portfolio by integrating both digital and traditional sales channels. Spectrum Pharmaceuticals, also US-based, focuses on developing and commercializing innovative oncology treatments, including the long-acting G-CSF product ROLVEDON, positioning Assertio to accelerate product launches and revenue growth.

View the full recombinant human granulocyte colonystimulating factor injection rhgcsf market report:
https://www.thebusinessresearchcompany.com/report/recombinant-human-granulocyte-colonystimulating-factor-injection-rhgcsf-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR

Innovations Shaping the Recombinant Human Granulocyte Colony-Stimulating Factor Injection rhG-CSF Market
Leading companies in the rhG-CSF market are focusing on creating advanced formulations like PEG-free recombinant G-CSF fusion proteins. These novel drugs are designed to prolong the medication's half-life, reduce the frequency of injections, and improve patient adherence, all while effectively preventing chemotherapy-induced neutropenia. PEG-free recombinant G-CSF fusion proteins are engineered by combining G-CSF with a human Fc fragment without using polyethylene glycol (PEG), enhancing drug stability and extending its action in the body.

An example of such innovation occurred in November 2024 when Evive Biotech Co. Ltd. of China partnered with Germany's APOGEPHA Arzneimittel GmbH to launch Ryzneuta (Efbemalenograstim alfa Injection) in the German market. This long-acting, PEG-free rhG-CSF product is manufactured using Chinese Hamster ovary* (CHO) cells to ensure mammalian glycosylation patterns, and it works by binding to G-CSF receptors to stimulate the growth and differentiation of neutrophils. Its unique Fc-fusion structure extends the half-life, reduces injection frequency, and boosts immune function, helping to avoid chemotherapy dose reductions or delays. Clinical trials have confirmed its safety and effectiveness, marking a significant advancement over traditional rhG-CSF injections.

Segmentation Overview of the Recombinant Human Granulocyte Colony-Stimulating Factor Injection rhG-CSF Market
This market is categorized based on several key factors:
1) Type: Filgrastim and Lenograstim
2) Route of Administration: Subcutaneous Injection and Intravenous Injection
3) Patient Type: Pediatric Patients and Adult Patients
4) Application: Cancer and Bone Marrow Disorders
5) Distribution Channel: Hospital Pharmacies and Retail Pharmacies

Further breakdown includes:
- Filgrastim subtypes: Neupogen, Zarxio, Accofil, Granix
- Lenograstim varieties: Neutrogin, Lenograstim Biosimilar, Lenograstim Standard Formulation, and Lenograstim Lyophilized Powder

This detailed segmentation helps in understanding the diverse options and delivery methods available in the rhG-CSF market, catering to various patient needs and treatment protocols.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Market Segmentation, Major Trends, and Competitive Analysis of the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (RhGCSF) Market here

News-ID: 4404568 • Views:

More Releases from The Business Research Company

Worldwide Trends Examination: The Fast-Paced Development of the Motion Control M …
The motion control market is poised for significant expansion as industries increasingly adopt advanced automation technologies. With rising investments and technological breakthroughs, this sector is set to transform manufacturing and related fields by 2030. Let's explore the market's size, leading companies, emerging trends, and segment forecasts to understand its evolving landscape. Expected Growth and Market Size of the Motion Control Market by 2030 The motion control market is on track for
Global Trends Overview: The Rapid Evolution of the Voice Picking Language Models Market
Global Trends Overview: The Rapid Evolution of the Voice Picking Language Models …
The voice picking language models market is poised for significant expansion in the coming years, driven by technological advancements and increasing adoption in logistics and warehouse environments. This sector is rapidly evolving as businesses prioritize efficiency and accuracy in their operations. Let's explore the market's size, growth factors, key companies, segmentation, and emerging trends shaping its future. Projected Market Size and Growth Trajectory for the Voice Picking Language Models Market
Leading Companies Enhancing Their Presence in the Viral Arthritis Vaccine Market
Leading Companies Enhancing Their Presence in the Viral Arthritis Vaccine Market
The viral arthritis vaccine sector is on the cusp of remarkable expansion, driven by advancements in vaccine technology and growing global health needs. As concerns about viral-induced joint diseases intensify, this market is poised for significant growth and innovation over the coming years. Let's explore the current market outlook, key players, trends shaping the industry, and the main segments defining this evolving field. Projected Market Growth and Value of the Viral
Future Projections: Key Trends Shaping the Thermal Cyclers Market Up to 2030
Future Projections: Key Trends Shaping the Thermal Cyclers Market Up to 2030
The thermal cyclers market is gaining considerable traction as advancements in biotechnology and diagnostics continue to evolve. With growing interest in precision medicine and rapid testing solutions, this market is set to experience notable growth in the coming years. Here's an in-depth look into its projected value, leading companies, emerging innovations, and key segments shaping the industry. Projected Market Value of the Thermal Cyclers Market by 2030 The thermal cyclers

All 5 Releases


More Releases for Injection

Chinese Injection Molding: Ezra Made Emerges as a Global Strategic Partner for I …
Image: https://www.globalnewslines.com/uploads/2025/11/1762824589.jpg Ezra Made offers integrated engineering and project management for global clients seeking transparent and quality-focused Chinese injection molding services. Global manufacturers navigating complex supply chains are increasingly turning to China for precision components, yet challenges persist in quality control and project management. Ezra Made, a Chinese injection molding [https://ezramade.com/] facility based in Dongguan, is addressing this gap by positioning itself not just as a supplier, but as an integrated engineering
04-22-2024 | Sports
ABNewswire
China injection mold company and What is injection mold
Nowadays plastic goods' application fully our life,whatever in household or industrial. But do you really know how to make a plastic product? Keep reading, this article will tell you. What is injection mold Injection molding usually defined as a thermoplastic polymer is heated above its melting point, resulting in the conversion of the solid polymer to a molten fluid with a reasonably low viscosity. This melt is mechanically forced, that is,
Diabetes Injection Pens Market - Innovative Tools for Diabetes Control: Injectio …
Newark, New Castle, USA: The "Diabetes Injection Pens Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Diabetes Injection Pens Market: https://www.growthplusreports.com/report/diabetes-injection-pens-market/7639 This latest report researches the industry
Global Light Vehicle Fuel Injection Market Size, Share and Trends Analysis Repor …
The global light vehicle fuel injection market is anticipated to grow at a CAGR of 3.4% during the forecast period (2022-2028). The major factor is the increasing sales of private vehicles across the globe. After COVID-19, people realize they need their personal vehicles to commute from one place to another. The majority of the sales of cars and bikes are happening in emerging economies, and generally, cars having 1200-1500 cc
Injection Molding Materials Market Report 2018: Segmentation by Material (Plasti …
Global Injection Molding Materials market research report provides company profile for ExxonMobil, BASF, Dow, Huntsman, Eastman, INEOS, SABIC, Magna International, Newell Rubbermaid, Beckton Dickinson, IAC group and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Tags---- Gasoline Direct Injection GDI Market, Market Research Report, Industry …
Market Research Reports Search Engine (MRRSE) has recently updated its massive report catalogue by adding a fresh study titled “Global Gasoline Direct Injection (GDI) Market – Analysis, Trends, Growth opportunity and Forecasted during (2018 – 2023)”. This business intelligence study encapsulates vital details about the market current as well as future status during the mentioned forecast period of 2026.The report also targets important facets such as market drivers, challenges, latest